NCT06420219

Brief Summary

This study evaluates the cell and biomarkers associated with the aggressive behavior of cancer.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
35mo left

Started Mar 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress42%
Mar 2024Mar 2029

First Submitted

Initial submission to the registry

March 25, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

March 25, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 17, 2024

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 25, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 25, 2029

Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

4 years

First QC Date

March 25, 2024

Last Update Submit

April 24, 2026

Conditions

Head and Neck Carcinoma

Outcome Measures

Primary Outcomes (2)

  • Overall survival

    Up to 5 years

  • Disease free survival

    Up to 5 years

Study Arms (1)

Observational

Patients undergo photography, blood sample collection, tissue collection and have their medical records reviewed on study.

Other: Non-Interventional Study

Interventions

Non-Interventional StudyOTHER

Non-interventional study

Observational

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with a new diagnosis of head and neck cancer

You may qualify if:

  • Diagnosis/disease status: New diagnosis of head and neck cancer
  • Allowable type and amount of prior therapy: No prior treatment
  • Age ≥ 18 years.
  • Ability to understand and the willingness to sign a written informed consent.

You may not qualify if:

  • Patients who have had treatment of head and neck cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

USC / Norris Comprehensive Cancer Center

Los Angeles, California, 90033, United States

RECRUITING

Study Officials

  • Albert Y Han, MD

    University of Southern California

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sandy Tran, MS

CONTACT

323-865-0451sandy.tran@med.usc.edu

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 25, 2024

First Posted

May 17, 2024

Study Start

March 25, 2024

Primary Completion (Estimated)

March 25, 2028

Study Completion (Estimated)

March 25, 2029

Last Updated

April 28, 2026

Record last verified: 2026-04

Locations

US(1)